Co-Authors
This is a "connection" page, showing publications co-authored by William Parker and Ayodeji Adegunsoye.
Connection Strength
0.516
-
Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection-response to Guangting Zeng and Yuchi Zhou. Lancet Reg Health Am. 2023 Oct; 26:100611.
Score: 0.230
-
Pharmacotherapy and pulmonary fibrosis risk after SARS-CoV-2 infection: a prospective nationwide cohort study in the United States. Lancet Reg Health Am. 2023 Sep; 25:100566.
Score: 0.227
-
Risk Factors for Hospital Readmission in Patients With Interstitial Lung Disease. Respir Care. 2024 Apr 22; 69(5):586-594.
Score: 0.060